US20120258876A1 - Nucleic acid beacons for fluorescent in-situ hybridisation and chip technology - Google Patents

Nucleic acid beacons for fluorescent in-situ hybridisation and chip technology Download PDF

Info

Publication number
US20120258876A1
US20120258876A1 US12/445,202 US44520207A US2012258876A1 US 20120258876 A1 US20120258876 A1 US 20120258876A1 US 44520207 A US44520207 A US 44520207A US 2012258876 A1 US2012258876 A1 US 2012258876A1
Authority
US
United States
Prior art keywords
nucleic acid
sequence
hybrid
enzyme
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/445,202
Other languages
English (en)
Inventor
Ian Thrippleton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metasystems Indigo GmbH
Original Assignee
miacom Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by miacom Diagnostics GmbH filed Critical miacom Diagnostics GmbH
Assigned to MIACOM DIAGNOSTICS GMBH reassignment MIACOM DIAGNOSTICS GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: THRIPPLETON, IAN
Publication of US20120258876A1 publication Critical patent/US20120258876A1/en
Assigned to METASYSTEMS INDIGO GMBH reassignment METASYSTEMS INDIGO GMBH NUNC PRO TUNC ASSIGNMENT (SEE DOCUMENT FOR DETAILS). Assignors: MIACOM DIAGNOSTICS GMBH
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation

Definitions

  • the present invention relates to beacons for fluorescent in-situ hybridisation and chip technology.
  • micro-organisms Grouping of micro-organisms and the very rapid testing for presence/absence of specific or a range of micro-organisms is also of relevance in other fields of microbiological testing: Blood banks, Pharmaceutical industry, Cosmetic industry and the Food industry. Frequently the same organisms are of relevance throughout the disciplines and reaction conditions therefor need to be standardised for all probes.
  • FISH Fluorescent in-situ Hybridisation
  • utilising chip technology represents an efficient way of utilising sensitivity and specificity of DNA-probes without having to use an enzymatic amplification step.
  • FISH relies on two approaches to the in-situ detection of targets generating a signal strong enough to be detected with standard measuring devices such as an epifluorescence microscope:
  • FISH technology for the identification of micro-organisms in their respective environments is well known in the art.
  • Application of FISH for the detection of pathogens is of especial interest to the clinical microbiology and infectiology, where FISH excels in speed and cost efficiency.
  • Detecting rRNA with chip technology also relieves from the necessity to amplify the target.
  • Total rRNA is extracted from a sample and placed on a chip.
  • Specific probes are concentrated on a small surface area and attract respective rRNA-molecules to give specific presence/absence signals. In order to make such chips economically viable they need to be used repeatedly with as little manipulations as possible. Furthermore the standardisation of probe characteristics is paramount for the generation of reproducible results.
  • probes In order to gain acceptance in a routine environment probes must be designed in such a way that all probes for one disease state can be run simultaneously under identical conditions in or on one vessel (chips, micro-fluidic devices or micro titre plates). In the design of the probes and to make the probes economically viable, it must - be taken into account that one probe may be of relevance to different disease states. Therefor, not only one set of probes but all probes must work under identical hybridisation conditions.
  • a further problem in both FISH and chip technology is that the procedure calls for a stringent wash step to remove unbound probes, requiring additional handling steps, reagents and time.
  • the success of a hybridisation may depend largely on the skill and precision applied to the washing step.
  • routine applications call for minimal steps and hands-on time, most importantly they must be independent from individual skills.
  • beacon fluorescence resonance energy transfer
  • PNA peptide nucleic acid
  • Patent CA 2176266/EP 0745690 gives guidance to the construction of universal stems for real time PCR (9). Surprisingly, these recommendations do not render working beacons when combined with probes designed to identify micro-organisms in-situ.
  • Real time PCR is performed in solution while both ISH (in-situ hybridisation) and chips require fixed targets. Their thermodynamic details were not compatible with in-situ hybridisation and FRET requirements. Thus, universally working stems could not be predicted for applications with fixed targets. It was therefore necessary to empirically search for specific beacons fitting individual oligo-nucleotide or nucleotide analogues in order to accomplish a plurality of beacons working under identical ISH specifications.
  • ISH-beacons care has to be taken that the stem does not hinder the delicate balance of hybridising towards RNA entwined in large protein/RNA complexes such as ribosomes.
  • the accessibility of binding sites is widely discussed in the art and is summarised in (1).
  • beacon probes Further limitations in the design of a beacon probe are given by the size of pores generated in the cell wall during the ISH procedure. Adding the same stem to different probes results in distinctly individual beacons. A plurality of probes already form hairpin loops and the addition of a stem does not result in a “beacon” formation. In addition, simply adding bases to form complementary pairs may increase the T m to such an extent that the hairpin is thermodynamically preferred rather than the hybrid formation. Special stems have to be devised that pull the sequence into beacon formation while maintaining the T m at or below that of the hybrid. The teachings with respect to the design of beacons (13) show that the increase of the stem length by one base pair increases the T m by 5° C. and that the T m of the stem should be 10° C. higher than the T m of the hybridising sequence.
  • FISH with single microorganisms, such as bacteria, based upon specific rRNA sequences, may be difficult due to sterical hindrance of the rRNA in the ribosome.
  • a beacon forming a hairpin may poorly anneal to the embedded rRNA target sequence.
  • Subject of the present invention is a nucleic acid capable of forming a hybrid with a target nucleic acid sequence and capable of forming a stem-loop structure if no hybrid is formed with the target sequence, said nucleic acid comprising
  • the nucleic acid of the present invention capable of forming a hybrid with a target nucleic acid sequence and capable of forming a stem-loop structure if no hybrid is formed with the target sequence is also referred herein as “beacon”, “molecular beacon”, “hairpin”, or “hairpin loop”, wherein the “open” form (no stem is formed) as well as the “closed” form (the beacon forms a stem) is included.
  • the open form includes a beacon not forming a hybrid with a target sequence and a beacon forming a hybrid with the target sequence.
  • the two complementary sequences (a2) are flanking the sequence (a1), i.e. the first sequence (a2) is attached at the 3′ end of the sequence (a1) and the second sequence (a2) is attached at the 5′ end of the sequence (a1).
  • hybrid with the cognate sequence is also referred herein as “hybrid with the cognate sequence” or as “cognate hybrid”.
  • the effector may be attached at one of the two complementary sequences capable of forming a stem, whereas the inhibitor may be attached at the other of the two complementary sequences, so that the inhibitor essentially inhibits the effector activity when a stem is formed, and that the effector is active when the hairpin is open.
  • the effector is attached at the 5′ end or the 3′ end of the beacon, respectively, or at a position which is 1, 2, 3, 4, or 5 nucleotides distant to the 5′ end or the 3′ end, respectively.
  • the inhibitor is preferably attached at the other end not covered by the effector, i.e. at the 3′ end or the 5′ end, respectively, or at a position which is 1, 2, 3, 4, or 5 nucleotides distant to the 3′ end or the 5′ end, respectively.
  • Hybridisation of the beacon of the present invention with target sequence may take place under conditions where the loop is open.
  • a beacon which is not forming a stem when hybridizing is capable of annealing to a target rRNA sequence, for instance, and can therefor achieve successful hybridisation.
  • T m of the beacon i.e. the T m of the stem
  • the T m of the cognate hybrid i.e. the hybrid of the beacon with the target sequence
  • “Essentially equal T m ” of the cognate hybrid and the stem of the beacon refers to melting temperatures differing in less than 5° C., preferably less than 3° C., more preferably less than 2° C., more preferably less than 1° C., more preferably less than 0.5° C., even more preferably less than 0.2° C., most preferably less than 0.1° C.
  • stem formation In order to achieve an inhibition of the effector by the inhibitor, both of which form part of the beacon, in those beacon molecules not hybridising with the target sequence, stem formation must be induced after the hybridisation reaction. This may for instance be achieved by a beacon having a ⁇ G ⁇ 0, so the hairpin will form spontaneously. Further, stem formation may be introduced by washing with a Mg 2+ containing buffer as described herein.
  • the hairpin loops are constructed in such a way that under standardised hybridisation conditions (e.g. under essentially Mg 2+ free conditions) the beacon stem is open so that possible sterical limitations do not hinder the hybridisation process.
  • sterical limitations may be present when the target sequence is a rRNA sequence. If the effector is a fluorophor, the fluorophor will not be quenched by the close proximity of ribosomal proteins.
  • Suitable conditions for induction of stem formation after hybridisation include an. Mg 2+ containing buffer, for instance containing about 1 to about 20 mM Mg 2+ , more particular about 5 to about 15 mM Mg 2+ , even more particular about 8 to about 12 mM Mg 2+ , most particular about 10 mM Mg 2+ .
  • the buffer may have a pH>8.
  • beacons function in their entirety and cannot be dissected into stem and loop as nearest neighbour and stacking effect have a profound influence in their thermodynamic properties.
  • Preferred beacons of the present invention are summarised in Table 1. They clearly show that the preferred stem sequence is independent from the ⁇ G, T m , GC content or length of the sequence chosen to identify a species.
  • thermodynamic specifications for the individual construction of beacons suitable for standardised conditions are set:
  • the Gibbs energy ( ⁇ G) for the formation of the beacon has to be designed in such a way that
  • the ⁇ G of the cognate hybrid is in the range of about ⁇ 17 to about ⁇ 25 kcal/mol, preferably about ⁇ 18 to about ⁇ 24 kcal/mol, more preferably about ⁇ 19 to about ⁇ 23 kcal/mol, most preferably about ⁇ 20 to about ⁇ 22 kcal/mol under hybridisation conditions.
  • the ⁇ G of the cognate hybrids under hybridisation conditions do not vary more than 5 kcal/mol, preferably no more than 3 kcal/mol, more preferably 2 kcal/mol and most preferably 1 kcal/mol.
  • the target sequence is a rRNA sequence
  • this renders the effector, e.g. the fluorophor, in very close proximity to potentially quenching proteins of the ribosome.
  • the stem is extended.
  • this can be achieved by the introduction of at least one non-matched nucleotide or nucleotide analogue.
  • introduction of at least one non-matched nucleotide may be enhanced by the introduction of an additional nucleotide or nucleotide analogue, so that the two complementary sequences have a different length, and the stem becomes “bended” (see for example position 36 in SEQ ID NO:1), or/and may be achieved by a replacement of a matching nucleotide or nucleotide analogue by a non-matching nucleotide or nucleotide analogue (see for example position 5 in SEQ ID NO: 7).
  • the “complementary sequences capable of forming a stem” may also include at least one non-matched nucleotide, preferably 1, 2, 3, 4 or 5 non-matched nucleotides.
  • the beacon of the present invention is not a PNA beacon.
  • the backbone of the beacon is preferably a nucleic acid backbone.
  • the beacon may comprise a nucleic acid analogue such as a deoxyribonucleotide analogue or a ribonucleotide analogue in the nucleic acid portion or/and in the linker if a linker is present.
  • This analogue is preferably a nucleotide analogue modified at the sugar moiety, the base or/and the phosphate groups.
  • the nucleotide analogue is preferably not a PNA building block.
  • pathogens can be grouped into disease related groups. Probes towards these organisms must work simultaneously under the said conditions, especially if all probes are to be utilised on one chip.
  • the chip application calls for a stringent standardisation of both the cognate and stem characteristics. If a combination of more than one probe is employed, i. e. at least two probes, all probes have to be designed to work on the same slide/chip simultaneously.
  • Another subject of the present invention is a combination comprising at least 2, preferably at least 10, at least 20, at least 30, at least 40, or at least 50 beacons.
  • the combination may comprise but is not limited to all of the beacons of Table 1, preferably at the maximum 100, at the maximum 80, at the maximum 70, at the maximum 60, at the maximum 50, at the maximum 40, at the maximum 30 or at the maximum 20 beacons.
  • the beacons may have the same or different target sequences. It is preferred that the target sequences of individual beacons are different.
  • the ⁇ G difference of the individual beacons of the hybrid of the sequences of (a2) or/and the hybrid of the sequence of (a1) with a target sequence may be at the maximum about 4 kcal/mol, preferably at the maximum about 3 kcal/mol, more preferably at the maximum about 2 kcal/mol, and most preferably at the maximum about 1 kcal/mol with respect to the cognate sequence.
  • the T m values of individual beacons with respect to its respective cognate sequence may differ at the maximum by about 3° C., preferably at the maximum about 2° C., more preferably at the maximum about 1° C.
  • the individual nucleic acids function uniformly. “Functioning uniformly” means that successful hybridisation can be achieved with different nucleic acids probes of the present invention under the same hybridisation conditions, for instance under standardised hybridisation conditions. In other words, uniformly functioning nucleic acids of the present invention do not require individual optimisation of the hybridisation conditions.
  • kits or chip which may contain at least two beacons of Table 1 required to detect the listed organisms optionally together with the required hybridisation reagents,
  • the chip or kit contains at least 10, at least 20, at least 30, at least 40, or at least 50 beacons.
  • the kit or chip may contain at the maximum all of the beacons of Table 1, preferably at the maximum 100, at the maximum 80, at the maximum 70, at the maximum 60, at the maximum 50, at the maximum 40, at the maximum 30 or at the maximum 20 beacons.
  • the beacons can be applied to assays designed to be performed in tubes, microtitre plates, filtered microtitre wells, slides and chips.
  • the detection can be made with fluorescence, time resolved fluorescence, with a plurality of fluorophores and utilising electrochemical enzymes.
  • the assay is performed on glass slides designed to hold and separate several samples.
  • Another subject of the present invention is a hybridisation method comprising
  • the sample may be any sample of biological origin, such as a clinical or food sample, suspected of comprising a nucleic acid to be detected by the beacon.
  • the sample may be a sample comprising microorganisms, such as bacteria, yeasts and molds, in particular Gram positive or/and Gram negative bacteria.
  • kits or chip as described herein.
  • Essentially free of Mg 2+ refers to a Mg 2+ concentration of less than 1 mM, preferably less than 0.1 mM, more preferably less than 0.05 mM, most preferably less than 0.01 mM.
  • the buffer in step (c) may contain about 1 to about 20 mM Mg 2+ , more particular about 5 to about 15 mM Mg 2+ , even more particular about 8 to about 12 mM Mg 2+ , most particular about 10 mM Mg 2+ .
  • Any suitable hybridisation protocol comprising application of an essentially Mg 2+ free solution and a Mg 2+ containing solution as indicated above may be applied.
  • the following protocol may be used: Aliquots of clinical samples are applied to defined fields on the slides. Preferably a defined quantity of 10 ⁇ l is applied and dried.
  • the detection may be via flow-cytometry or automated fluorescence reader well known in the art.
  • Yet another embodiment of the present invention relates to Chip applications of the beacons of the present invention.
  • the beacons need to be covalently attached to a carrier surface.
  • the 3′-terminal base of the designed beacons may be either biotinylated or linked via a hetero-bifunctional reagent to an enzyme using methods well known in the art of protein and nucleic acid chemistry. Biotinylated beacons may then be added to Streptavidin coated chips as can be obtained freely from commercial sources (19).
  • the respective biotinylated hairpin loops can be attached to plurality of distinct fields of one chip, for instance at least 10, at least 50, at least 100, at least 200, or at least 500 fields, or at the maximum 500, at the maximum 400 or at the maximum 300 fields.
  • Total RNA can be extracted from samples using commercially available kits (20) and can be applied to the chip under hybridising conditions. After hybridisation the chip can be briefly washed with a magnesium containing buffer, for instance at pH>8. Fluorescence on a field marks the presence of specific target sequence, for instance a specific RNA indicating the presence of a respective organism in the sample.
  • a beacon of the present invention is covalently attached to an enzyme exerting a signal by catalysing a specific reaction.
  • the enzyme may exert an electrochemical signal.
  • Suitable enzymes comprise, but are not limited to tyrosinase, peroxidase, sulfite oxidase, alkaline phosphatase, glucose oxydase, guanine oxidase.
  • the enzyme is recombinantly derived from a genomic sequence of a thermo- or hyperthermophylic organism to render it stable under hybridisation conditions and elevated temperatures (21).
  • the enzyme may be attached to the beacon at one end of the beacon molecule.
  • an inhibitor may be attached which is capable of inhibiting the enzyme activity.
  • the inhibitor inhibits the enzyme and no signal is generated.
  • the loop will remain unfolded with the inhibitor well removed from the enzyme and the enzyme will produce an electrochemical signal which can be detected by devices well described in the art.
  • a linker may be employed for the attachment of the enzyme or/and the inhibitor, in particular for the attachment of the inhibitor.
  • glucose oxidase is attached to one end of the said hairpin loops and a glucose oxidase inhibitor, such as an adenine nucleotide or adenine nucleotide analogue is attached to the other end of the hairpin loop.
  • Adenine nucleotides are known inhibitors of glucose oxidase (22, 23).
  • a linker may be employed for the attachment of the glucose oxidase or/and the glucose oxidase inhibitor, in particular for the attachment of the glucose oxidase inhibitor.
  • RNA is extracted from a sample utilising extraction procedure and kits readily available on the market (20) and placed on the chip under hybridisation conditions. After the hybridisation the chip is washed with substrate buffer at 46° C. and the signal is read. At the end of the cycle all hybridised RNA is washed off with hybridisation buffer at elevated temperature. Preferably the wash temperature is chosen 10° C. above the respective T m . In a preferred embodiment the chip is washed at 60° C. with hybridisation buffer. The temperature may then dropped to 46° C. to equilibrate for the next analytical cycle.
  • beacon sequences of the present invention Abbreviations: R&G: a red or/and a green fluorescent dye may be attached to the beacon, such as Cy3 or FITC or a derivative thereof.
  • Table 2 describes that PNA beacons are not suitable in the present invention. Calculations were performed with the sequences of Table 1 assuming the beacon to be a PNA beacon. In contrast to DNA beacons, all of the following five criteria have to be fulfilled: GC content ⁇ 60%, ⁇ 3 bases selfcomplementary, 4 purines in a row, length of maximal 18, inverse sequence palindromes or repeats or hairpins. “Yes” (“No”) in Table 2 indicates that the criterion is fulfilled (not fulfilled). The column “Final” indicates if a PNA beacon is suitable in the present invention (“Yes”) or not (“No”). “No” in final indicates that one of the five criteria is not met. “Yes” would indicate that all criteria are met. All sequences of Table 2 are judged to be “No”. Thus, no one of the sequences of Table 1 would be suitable in a PNA beacon.
  • Tm 79.8+18.5 log M+ 58.4( XG+XC )+11.8( XG+XC )2 ⁇ 820/ L ⁇ 0.35 F
  • Tm 79.8+18.5 log M+ 58.4( XG+XC )+11.8( XG+XC )2 ⁇ 820/ L ⁇ 0.50 F

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
US12/445,202 2006-10-10 2007-10-10 Nucleic acid beacons for fluorescent in-situ hybridisation and chip technology Abandoned US20120258876A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06021267 2006-10-10
EP06021267.7 2006-10-10
PCT/EP2007/008811 WO2008043543A2 (fr) 2006-10-10 2007-10-10 Balises d'acides nucleiques pour l'hybridation in situ en fluorescence et technologie a puces

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/008811 A-371-Of-International WO2008043543A2 (fr) 2006-10-10 2007-10-10 Balises d'acides nucleiques pour l'hybridation in situ en fluorescence et technologie a puces

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/198,613 Continuation US8993239B2 (en) 2006-10-10 2014-03-06 Nucleic acid beacons for fluorescent in-situ hybridization and chip technology

Publications (1)

Publication Number Publication Date
US20120258876A1 true US20120258876A1 (en) 2012-10-11

Family

ID=39283224

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/445,202 Abandoned US20120258876A1 (en) 2006-10-10 2007-10-10 Nucleic acid beacons for fluorescent in-situ hybridisation and chip technology
US14/198,613 Expired - Fee Related US8993239B2 (en) 2006-10-10 2014-03-06 Nucleic acid beacons for fluorescent in-situ hybridization and chip technology

Family Applications After (1)

Application Number Title Priority Date Filing Date
US14/198,613 Expired - Fee Related US8993239B2 (en) 2006-10-10 2014-03-06 Nucleic acid beacons for fluorescent in-situ hybridization and chip technology

Country Status (12)

Country Link
US (2) US20120258876A1 (fr)
EP (1) EP2097541B1 (fr)
JP (1) JP5645407B2 (fr)
CN (1) CN101573454A (fr)
AU (1) AU2007306616B2 (fr)
CA (1) CA2667631C (fr)
DK (1) DK2097541T3 (fr)
ES (1) ES2401183T3 (fr)
HK (1) HK1134324A1 (fr)
PL (1) PL2097541T3 (fr)
PT (1) PT2097541E (fr)
WO (1) WO2008043543A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2623859T3 (es) * 2010-03-04 2017-07-12 Miacom Diagnostics Gmbh FISH múltiple mejorada
EP2428582B1 (fr) 2010-09-14 2013-09-04 miacom Diagnostics GmbH Tampon de marge
EP2500435B1 (fr) 2011-03-18 2016-09-21 miacom Diagnostics GmbH Identification de résistance antibiotique dans les micro-organismes
EP2756097B1 (fr) 2011-07-29 2022-03-02 MetaSystems Indigo GmbH Procédé pour détecter une résistance aux antibiotiques
CN102998439A (zh) * 2011-09-14 2013-03-27 佳木斯大学 同时检测葡萄糖、尿酸、甘油三酯及胆固醇的微流控纸芯片及制造方法
PT107037B (pt) * 2013-07-03 2017-09-13 Chromoperformance S A Sonda de ácido péptido nucleico (pna), estojo e método para deteção de aspergillus fumigatus e respetivas aplicações
EP3325621B1 (fr) * 2015-07-17 2021-06-30 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Clonage d'arn simple brin
EP3118313A1 (fr) * 2015-07-17 2017-01-18 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Clonage d'arn simple brin
EP3290527B1 (fr) 2016-08-29 2019-06-19 MetaSystems Indigo GmbH Procédé de détection de micro-organismes dans un échantillon

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030232377A1 (en) * 2002-06-13 2003-12-18 New York University Early noninvasive prenatal test for aneuploidies and heritable conditions
US20090029867A1 (en) * 2005-01-26 2009-01-29 Reed Michael W DNA purification and analysis on nanoengineered surfaces

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6692965B1 (en) * 1999-11-23 2004-02-17 Chromocell Corporation Isolation of living cells and preparation of cell lines based on detection and quantification of preselected cellular ribonucleic acid sequences
ATE434167T1 (de) * 2003-03-07 2009-07-15 Univ New Jersey Med Optisch dekodierbare mikroträger, arrays und verfahren
WO2006060561A2 (fr) * 2004-12-01 2006-06-08 Emory University Methodes et applications d'imagerie par sonde moleculaire pour la detection de cellules cancereuses

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030232377A1 (en) * 2002-06-13 2003-12-18 New York University Early noninvasive prenatal test for aneuploidies and heritable conditions
US20090029867A1 (en) * 2005-01-26 2009-01-29 Reed Michael W DNA purification and analysis on nanoengineered surfaces

Also Published As

Publication number Publication date
EP2097541A2 (fr) 2009-09-09
DK2097541T3 (da) 2013-03-18
PT2097541E (pt) 2013-03-18
JP2010505429A (ja) 2010-02-25
JP5645407B2 (ja) 2014-12-24
WO2008043543A3 (fr) 2008-07-24
AU2007306616B2 (en) 2012-05-17
CA2667631A1 (fr) 2008-04-17
CA2667631C (fr) 2017-11-07
EP2097541B1 (fr) 2012-12-12
US8993239B2 (en) 2015-03-31
PL2097541T3 (pl) 2013-06-28
US20140255926A1 (en) 2014-09-11
AU2007306616A1 (en) 2008-04-17
HK1134324A1 (en) 2010-04-23
WO2008043543A2 (fr) 2008-04-17
CN101573454A (zh) 2009-11-04
ES2401183T3 (es) 2013-04-17

Similar Documents

Publication Publication Date Title
AU2007306616B2 (en) Nucleic acid beacons for fluorescent in-situ hybridisation and chip technology
EP2363502B1 (fr) FISH de multiplexage amélioré
JP3850914B2 (ja) 検出可能にラベルされた二元的形態、オリゴヌクレオチドプローブ、アッセイおよびキット
US7205104B2 (en) Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays
US20030105320A1 (en) Affinity-shifted probes for quantifying analyte polynucleotides
JP2016073312A (ja) 増幅核酸検出方法及び検出デバイス
US20150344939A1 (en) Methods and Compositions For Sorting and/or Determining Organisms
US11193162B2 (en) Nucleic acid detection or quantification method using mask oligonucleotide, and device for same
US20160046984A1 (en) Robust Detection of Nucleic Acids in Situ
EP1766072A2 (fr) Hybridation de sondes pna dans des solutions alcooliques
US20100216146A1 (en) Methods and Kits for Hybridizing Multiple PNA Probe Panels to Nucleic Acid Samples
US6905824B2 (en) Methods for determining organisms not requiring the separation of fixative or excess probe
JP4441259B2 (ja) グラム陽性菌の検出方法
US20020155456A1 (en) Method of amplification for increasing the sensitivity of detecting nucleic acid-probe target hybrids
JP3735400B2 (ja) メチシリン耐性黄色ブドウ球菌の検出法及びキット
JP2008142009A (ja) Ｐｎａプローブを利用した検体中の目的ｄｎａまたはｒｎａの検出方法及び検出用キット、ｐｎａプローブとハイブリダイズさせる目的ｄｎａまたはｒｎａの調製方法及び調製用キット、ならびに目的ｄｎａまたはｒｎａを検出するためのｐｎａチップ。
EA006579B1 (ru) Выявление индуцибельных генов в микроорганизмах

Legal Events

Date Code Title Description
AS Assignment

Owner name: MIACOM DIAGNOSTICS GMBH, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:THRIPPLETON, IAN;REEL/FRAME:022896/0753

Effective date: 20090510

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: METASYSTEMS INDIGO GMBH, GERMANY

Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:MIACOM DIAGNOSTICS GMBH;REEL/FRAME:049354/0264

Effective date: 20190430